Search Results
Locally Advanced HER2+ Breast Cancer
Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani
Lasofoxifene vs fulvestrant for locally advanced/metastatic ER+/HER2- breast cancer: ELAINE trial
Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets
Management of HER2 positive metastatic breast cancer treatment algorithm
H3B-6545 in women with locally advanced/metastatic ER+, HER2 negative breast cancer
Dr. McCann on Prognosis for Patients With HER2-Positive Breast Cancer
[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally advanced or metas...
Mercoledì dell'Oncologia | Highlights da ESMO 2024
Understanding Treatment for Locally Advanced Breast Cancer: Comprehensive Guide
Changing landscape in the management of HER2 positive locally advanced and metastatic breast cancer
Trastuzumab Duocarmazine for HER2+ Locally Advanced or Metastatic Cancer